Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Why Am I Not Losing Weight on Semaglutide
Use it exactly as you would a tirzepatide-only vial
References: FDA Mounjaro Approval, FDA Zepbound Approval Indications and Contraindications Approved Uses Type 2 diabetes mellitus (as an adjunct to diet and exercise) Chronic weight management in adults with BMI 30 kg/m, or 27 kg/m with at least one weight-related comorbidity Contraindications Personal or family history of medullary thyroid carcinoma (MTC) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Hypersensitivity to tirzepatide or any component of the formulation Note: Tirzepatide is not indicated for use in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis
This uncertainty can delay appropriate dose escalation
Patients who prepare for the peak side effect period (weeks 6 to 8) by stocking appropriate foods and having anti-nausea remedies ready report 40% less severe symptoms than those who react to symptoms after they appear
US$ 29.36
US$ 20.57
US$ 25.39
US$ 23.66
